The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Evaluating Treatments for Painful Diabetic Neuropathy
February 13th 2014Meta-analysis of clinical trial data on the use of antidepressants and anticonvulsants for the treatment of painful diabetic neuropathy indicates gabapentin is the most efficacious agent for this condition, while the side effects associated with amitriptyline make it the least tolerable treatment option evaluated in the study.
Meeting Report: World Diabetes Congress
February 3rd 2014Five presentations from the World Diabetes Congress are highlighted, covering studies of long-acting Lantus insulin, affordability of care, DPP-4 inhibitors and heart failure in diabetes, brown versus white rice to reduce obesity and diabetes, and the converging pandemics of diabetes and tuberculosis.
Increasing Protein Intake Won't Weaken Renal Function in Diabetics
January 27th 2014Until recently, it was unclear whether high-protein diets accelerate renal disease in susceptible individuals - including the roughly half of all diabetics who experience complete renal failure as a result of elevated glucose levels overworking the kidneys.
Thyroid Dysfunction Increases Cardiovascular Risks in Diabetic Dialysis Patients
January 24th 2014Though dialysis patients have a greater risk for thyroid disorders due to uremic toxins, protein malnutrition, and inflammation, the prevalence of those disorders and their impact on cardiovascular (CV) events and mortality have not been investigated.